Absence of AKT1 Mutations in Glioblastoma
暂无分享,去创建一个
Dirk Troost | W. Peter Vandertop | Sieger Leenstra | W. Vandertop | S. Leenstra | D. Troost | A. Bardelli | C. Zanon | F. Bleeker | S. Lamba | Alberto Bardelli | A. V. van Tilborg | Simona Lamba | Fonnet E. Bleeker | Carlo Zanon | Angela A. van Tilborg | Theo Hulsebos | T. Hulsebos
[1] Christian Hartmann,et al. PIK3CA mutations in glioblastoma multiforme , 2005, Acta Neuropathologica.
[2] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[3] Gaetano Rocco,et al. Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung , 2008, Cell cycle.
[4] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[5] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[6] U. Schüller,et al. Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas , 2008, Acta Neuropathologica.
[7] S. Gabriel,et al. Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain , 2006, PLoS medicine.
[8] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[9] Sieger Leenstra,et al. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. , 2007, Cancer research.
[10] G. Mills,et al. A new mutational AKTivation in the PI3K pathway. , 2007, Cancer cell.
[11] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[12] S. H. Lee,et al. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias , 2008, British Journal of Cancer.
[13] Andrew D. Yates,et al. Athletics: Momentous sprint at the 2156 Olympics? , 2004, Nature.
[14] Hanina Hibshoosh,et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. , 2005, Cancer research.
[15] M. Weller,et al. PIK3CA alterations in primary (de novo) and secondary glioblastomas , 2007, Acta Neuropathologica.
[16] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[17] D. Coradini,et al. PIK3CA cancer mutations display gender and tissue specificity patterns , 2008, Human mutation.
[18] G. Reifenberger,et al. Genetic alteration and expression of the phosphoinositol‐3‐kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas , 2005, Neuropathology and applied neurobiology.
[19] L. Stephens,et al. Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils , 1991, Nature.
[20] A. Marchetti,et al. AKT1E17K in human solid tumours , 2008, Oncogene.
[21] Spyro Mousses,et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer , 2007, Nature.
[22] A. Marchetti,et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors , 2009, Human mutation.